BILLAIRE CLINICAL LABS
docx
keyboard_arrow_up
School
York University *
*We aren’t endorsed by this school
Course
2700
Subject
Accounting
Date
Apr 3, 2024
Type
docx
Pages
4
Uploaded by CountPenguinMaster907
Radhika Goyal
220550521
Introduction
The US market for clinical laboratory testing was valued at $30 billion in 1998. Bellaire Clinical
Labs Inc. is a small, superb, independently owned clinical laboratory that is located outside of
Boston, Massachusetts. It is privately owned. The lab provides three distinct client groups—
doctors, particular patients, and third parties (Medicare, Medicaid, or a private insurance
company)—with routine blood testing and specialty testing in combination with flexible pricing
packages. Just a year ago, Marty Walters was chosen to be the operations manager of the lab
because of his experience in implementing significant process changes to reduce the quantity of
material use and waste and routinely praising employee actions to boost productivity. The net profit only increased by $6363 compared to the projected amount. The causes are still
unknown and require close examination.
Problem Statement
How did Bellaire accomplish so many process improvements? succeeded in bringing in an extra US$ approximately one million in sales without experiencing a noticeable decline in profits? Why did a $1 million US sales increase result in a meager $6363 profit difference over the projected amount?
Case Analysis
Calculating the discrepancy between Planned and A
Particulars
Actual Revenue
Planned Revenue
Variance
Result
Net Revenue
Routine Testing
11,676,904
12,160,000 (483,096)
Unfavourable
Specialty Testing
5,709,496
4,240,000
1,469,496
Favourable
Total Net Revenue
17,386,400
16,400,000
986,400
Favourable
Calculation of the net profit difference between the Actual and Budgeted amounts for the year ended in 1998.
Particulars
Actual Revenue
Planned Revenue
Variance
Result
Total Net Revenue
17,386,400
16,400,000
986,400
6.01▲
Less:
Material
2,760,000
2,700,000
(60,000)
2.22▲
Labour Routine
2,273,981
2,402,400
128,419
5.35▼
Labour Speciality
2,731,456
2,028,000
(703,456)
34.69▲
Depreciation
3,503,000
3,500,000
(3000)
0.09▲
Other costs of testing
1,120,000
1,100,000
(20,000)
1.82▲
Billing and collection costs
2,080,000
1,850,000
(230,000)
12.43▲
Radhika Goyal
220550521
Advertising and promotion
892,000
820,000
(72,000)
8.78▲
Management salaries
710,000
700,000
(10,000)
1.43▲
Other administrative costs
510,000
500,000
(10,000)
2.00▲
Net profit
16,580,437
15,600,400
6,363
0.80▲
Results
The overall sales revenue increased by 986400 $, nearly one million USD, or about 6% above the budgetary limits.
Specialty labor costs increased by about 35% compared to the annual budgeted amounts.
Following specialty labor expenses from their budgeted ones, billing and collection costs saw the second-highest increase. They exceeded the anticipated allotted limits by 12.4%.
Less than 10% more was spent on other expenses compared to the actual amounts allocated in the budget.
Contributing Elements
1.
No. of Tests
Particulars
Planned
Actual
Variance
No. of Tests
1,000,000
1,030,000
30,000
With the exception of the higher profitability factor, a significantly higher number of tests with underestimated budgeted variable expenses only increased revenue.
2.
Routine Test %
Particulars
Planned
Actual
Variance
% of Test
74%
80%
6%▼
No. of Tests Performed
762,200
800,000
4.73%▼
Significantly fewer routine tests than scheduled tests indicate fierce competition in
the market for this market segment. Bellaire did not alter their prices, though. As a
result, it increased the planned budgetary limits beyond their real value by more
overestimating labor costs. Consequently, even though total revenue exceeded
expectations at its peak, the profitability factor remained low.
Bellaire underperformed on testing by 6%. Bellaire's routine revenue fell short of
their projected amount by 4.73%.
Particulars
Planned
Actual
Variance
% of Test
26%
20%
6%▲
No. of Tests Performed
276,800
200,000
4.73%▲
Speciality Test
Radhika Goyal
220550521
Particulars
Planned
Actual
Variance
% of Tests by Physicians
44%
50%
6%▼
% of Tests by Patients
20%
20%
0%▲
% of Tests by Other Parties
36%
30%
6%▲
Bellaire generated 34% more revenue than anticipated despite underestimating by 6% the
planned
budget
amount
of
specialty
tests
conducted.
The price package bracket for specialty tests was higher ($20, $22, $23), and the labor
costs were higher ($19.6 per hour). Routine tests, in contrast, were priced in the package
range of $14, $16, and $17, with lower labor costs of $8.22 per hour.
The variable labor costs increased when the number of speciality tests was significantly
higher than the one budgeted for. As a result, it took up a sizable portion of the cost
factor, and increased revenue did not significantly increase profit.
Higher billing and collection costs from pre-budget tests result from performing more
specialty tests than budgeted.
Third-party billing also takes the longest in terms of administrative work. Recommendations
Price increases in response to high demand:
Bellaire should have been the one to raise
costs in response to high demand for specialty testing. They may have been able to offset
the high labor variable costs for the specialty tests and enhanced profitability as a result.
Develop a successful cost-cutting plan by bringing other costs under control and reducing
unnecessary spending, as labor costs are comparatively high. Reducing the excessive
amounts of unnecessary advertising expenses is necessary.
Research & Analysis:
Bellaire needs to make sure that their pricing packages are
tailored to the specific market conditions at the times that they are supposed to be created.
Formal Human Resource Management:
Bellaire must keep an eye on and responsibly
manage its human resources.
Conclusion
Every company wants to grow in terms of both revenue and profit. Any organization would be
happy to see Bellaire achieve a one-million-dollar revenue increase over budget. But it seems
that its enormous promotional expenses and rising variable labor costs are preventing it from
turning a profit. To mitigate these evident shortcomings, suitable management techniques and
strategies need to be implemented.
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Radhika Goyal
220550521
Related Documents
Related Questions
plese help me through these thakn you1
arrow_forward
Identify 2 weaknesses. Why are they weaknesses and what risk they expose the company to? What is the recommendation to correct the weakness?
arrow_forward
Domestic
arrow_forward
N10.
Account
arrow_forward
Don't use ai to answer I will report your answer Solve it Asap with explanation and calculation
arrow_forward
Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, describes itself in a recent annual report as follows.
Noven Pharmaceuticals, Inc.
Noven is a place of ideas—a company where scientific excellence and state-of-the-art manufacturing combine to create new answers to human needs. Our transdermal delivery systems speed drugs painlessly and effortlessly into the bloodstream by means of a simple skin patch. This technology has proven applications in estrogen replacement, but at Noven we are developing a variety of systems incorporating bestselling drugs that fight everything from asthma, anxiety and dental pain to cancer, heart disease and neurological illness. Our research portfolio also includes new technologies, such as iontophoresis, in which drugs are delivered through the skin by means of electrical currents, as well as products that could satisfy broad consumer needs, such as our anti-microbial mouthrinse.
Noven also reported in its annual report that its activities to…
arrow_forward
answer please
arrow_forward
The production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine
which one has the best average rate of return.
Machine A Machine B Machine C
$83,087.40 $73,001.40
322,364.00 276,958.00 486,676.00
Estimated average income $45,130.96
Average investment
Oa. Machine B
Ob. Machine C
Oc. Machine A
Od. Machines B and C have the same preferred average rate of return.
arrow_forward
Meman
arrow_forward
The production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine which one has the best average rate of return.
Line Item Description
Machine A
Machine B
Machine C
Estimated average income
$47,060.44
$72,961.50
$73,785.60
Average investment
336,146.00
243,205.00
491,904.00
a. Machine C
b. Machine A
c. Machines B and C have the same preferred average rate of return.
d. Machine B
arrow_forward
The production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine
which one has the best average rate of return.
Machine A
$43,529.50 $80,697.00
Machine B Machine C
$64,675.95
310,925.00 268,990.00 431,173.00
Estimated average income
Average investment
Oa. Machine B
Ob. Machine A
Oc. Machine C
Od. Machines B and C have the same preferred average rate of return.
arrow_forward
REA MODEL—CRYOGENICS' FIXED ASSET SYSTEM
Cryogenics Inc. is a leading developer, designer, and manufacturer of tanks, moveable containers, and trailers for the most efficient storage and distribution of liquid helium and hydrogen. Cryogenics started as a private company when founded in 1960 by industrialist William Hodges. It has since gone public and has grown to support a staff 250 employees between its Tulsa, Oklahoma, and Prague, Czech Republic, operations to meet the global demand for liquid helium and hydrogen storage with the highest
performance ratings in the industry. The following describes Cryogenics' fixed asset system.
Asset acquisition begins when the department manager recognizes the need to obtain or replace an existing fixed asset. The manager prepares two copies of a purchase requisition; one is filed in the department, and one is sent to the purchasing department. The purchasing department uses the purchase requisition to prepare three copies of a purchase order.…
arrow_forward
(b) Explain one advantage and one disadvantage for CH of having a mission statement.
(c) Explain two possible external sources of finance CH could use to continue production of
Copper Health (CH) was the market leader in the production of anti-venom* vaccines to treat
(CSR) – is to put customers first and profits second in the treatment of snake bites.
poisonous snake bites. CH's mission - influenced heavily by corporate social responsibility
Despite 100000 deaths worldwide each year from snake bites and 400000 serious injuries, CH
recently announced that it will no longer produce anti-venom vaccines. Several large Mexican,
Brazilian and Indian pharmaceutical companies have entered the market selling anti-venom
5. Copper Health (CH)
vaccines at a much lower price than CH.
A spokesperson for CH said: "We will remain a private limited company where corporate
Social responsibility (CSR) remains an important driving force for our mission. Our medical
research is only financed from retained…
arrow_forward
RESEARCH AND DEVELOPMENT - Financial Reporting
Alert Industries has spent $5 billion over the last three years in
developing a new drug labeled COVEX 22. FDA approval is expected
by the end of the month, at which time the drug will be available for sale.
None of Alert's competitors has a product similar to COVEX 22, and the
medical community is anxiously awaiting availability of this drug.
Although COVEX 22 promises to be a "wonder drug" with huge financial
success, Alert's income statements for the last few years have shown
substantial losses and Alert's statement of financial position only includes
$ 0.3 billion product COVEX 22 among the assets of the business.
Explain why one of Alert's seemingly most valuable assets apparently has
been reported for only $0.3 billion in the statement of financial position,
and why Alert's income statements for the past few years reported
substantial losses.
arrow_forward
B-MED is a medical equipment distributor that sells and services General Electric Healthcare, Medtronic Corporation, Steris Corporation, and AGFA Healthcare medical equipment in the Caribbean and Latin American Region. B-MED was founded in 1984 by Bob Samuels and was run as a small family-owned business with fewer than 10 employees for 25 years. B-MED sold small medical equipment such as EKG machines, patient monitors, anesthesia machines, and defibrillators. As there were only a few products in these lines, B-MED only required a small staff that consisted of three salespersons, five administrative persons, and two engineers. The staff was mostly composed of Samuels’s family members or friends of the family. The company was a traditional vertical organization where Samuels made all decisions. The employees were generally driven by extrinsic motives including fear of punishment and compensation and lacked intrinsic motivation as they lacked a sense of responsibility and accomplishment.…
arrow_forward
H-Robotic Incorporated (HRI), a world leader in the robotics industry, produces a line of industrial robots and peripheral equipment that performs many routine assembly-line tasks. However, increased competition, particularly from Japanese firms, has caused HRI's management to be concerned about the company's growth potential in the future. HRI's research and development department have been applying the industrial robot technology to develop a line of household robots. The household robot is designed to function as a maid, mainlyperforming such tasks as vacuuming floors and carpets. This effort has nowreached the stage where a decision on whether to go forward with production must be made. The engineering department has estimated that the firm would need a new manufacturing plant with the following construction schedule:
The plant would require a 35-acre site, and HRI currently has an option to purchase a suitable tract of land for $2.5 million. The building construction would begin…
arrow_forward
Mini Case
Lewis Securities Inc. has decided to acquire a new market data and quotation system for its Richmond home office. The system receives current market prices and other information from several online data services and then either displays the information on a screen or stores it for later retrieval by the firm’s brokers. The system also permits customers to call up current quotes on terminals in the lobby.
The equipment costs $1,000,000 and, if it were purchased, Lewis could obtain a term loan for the full purchase price at a 10% interest rate. Although the equipment has a 6-year useful life, it is classified as a special-purpose computer and therefore falls into the MACRS 3-year class. If the system were purchased, a 4-year maintenance contract could be obtained at a cost of $20,000 per year, payable at the beginning of each year. The equipment would be sold after 4 years, and the best estimate of its residual value is $200,000. However, because real-time display system…
arrow_forward
GB Pharmaceuticals produces and sells a single drug. XY-5. The company is organized into three divisions:
Manufacturing, Packaging, and Distribution. Manufacturing, located in country A, manufactures the drug producing a
single-dose capsule. The variable cost of a capsule is $34. The fixed costs of Manufacturing is $10 million and
Manufacturing produces 1 million capsules annually.
Packaging is located in country B. Packaging takes the pills that are sent by Manufacturing in bulk and packages them
In bottles containing 10 capsules each. The variable costs of packaging are $64 per bottle. The pills from
Manufacturing are transferred at average (variable plus fixed) costs. Fixed costs in packaging are $4 million annually.
Distribution, like Manufacturing, is located in country A. Distribution takes the bottles prepared by Packaging and sells
them to distributors In country A. The variable costs of Distribution are $74 per bottle. Fixed costs in Distribution are $3
million annually.
The…
arrow_forward
SEE MORE QUESTIONS
Recommended textbooks for you
Business/Professional Ethics Directors/Executives...
Accounting
ISBN:9781337485913
Author:BROOKS
Publisher:Cengage
Related Questions
- N10. Accountarrow_forwardDon't use ai to answer I will report your answer Solve it Asap with explanation and calculationarrow_forwardNoven Pharmaceuticals, Inc., headquartered in Miami, Florida, describes itself in a recent annual report as follows. Noven Pharmaceuticals, Inc. Noven is a place of ideas—a company where scientific excellence and state-of-the-art manufacturing combine to create new answers to human needs. Our transdermal delivery systems speed drugs painlessly and effortlessly into the bloodstream by means of a simple skin patch. This technology has proven applications in estrogen replacement, but at Noven we are developing a variety of systems incorporating bestselling drugs that fight everything from asthma, anxiety and dental pain to cancer, heart disease and neurological illness. Our research portfolio also includes new technologies, such as iontophoresis, in which drugs are delivered through the skin by means of electrical currents, as well as products that could satisfy broad consumer needs, such as our anti-microbial mouthrinse. Noven also reported in its annual report that its activities to…arrow_forward
- answer pleasearrow_forwardThe production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine which one has the best average rate of return. Machine A Machine B Machine C $83,087.40 $73,001.40 322,364.00 276,958.00 486,676.00 Estimated average income $45,130.96 Average investment Oa. Machine B Ob. Machine C Oc. Machine A Od. Machines B and C have the same preferred average rate of return.arrow_forwardMemanarrow_forward
- The production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine which one has the best average rate of return. Line Item Description Machine A Machine B Machine C Estimated average income $47,060.44 $72,961.50 $73,785.60 Average investment 336,146.00 243,205.00 491,904.00 a. Machine C b. Machine A c. Machines B and C have the same preferred average rate of return. d. Machine Barrow_forwardThe production department is proposing the purchase of an automatic insertion machine. It has identified three machines and has asked the accountant to analyze them to determine which one has the best average rate of return. Machine A $43,529.50 $80,697.00 Machine B Machine C $64,675.95 310,925.00 268,990.00 431,173.00 Estimated average income Average investment Oa. Machine B Ob. Machine A Oc. Machine C Od. Machines B and C have the same preferred average rate of return.arrow_forwardREA MODEL—CRYOGENICS' FIXED ASSET SYSTEM Cryogenics Inc. is a leading developer, designer, and manufacturer of tanks, moveable containers, and trailers for the most efficient storage and distribution of liquid helium and hydrogen. Cryogenics started as a private company when founded in 1960 by industrialist William Hodges. It has since gone public and has grown to support a staff 250 employees between its Tulsa, Oklahoma, and Prague, Czech Republic, operations to meet the global demand for liquid helium and hydrogen storage with the highest performance ratings in the industry. The following describes Cryogenics' fixed asset system. Asset acquisition begins when the department manager recognizes the need to obtain or replace an existing fixed asset. The manager prepares two copies of a purchase requisition; one is filed in the department, and one is sent to the purchasing department. The purchasing department uses the purchase requisition to prepare three copies of a purchase order.…arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- Business/Professional Ethics Directors/Executives...AccountingISBN:9781337485913Author:BROOKSPublisher:Cengage
Business/Professional Ethics Directors/Executives...
Accounting
ISBN:9781337485913
Author:BROOKS
Publisher:Cengage